ERTACZO

This brand name is authorized in Mexico, United States

Active ingredients

The drug ERTACZO contains one active pharmaceutical ingredient (API):

1 Sertaconazole UNII 1DV05410M5 - SERTACONAZOLE NITRATE

Sertaconazole, an azole antifungal agent, inhibits fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylase enzyme. This enzyme functions to convert lanosterol to ergosterol. Ergosterol is a key component of fungal cell membranes and lack of this component leads to fungal cell injury by leakage of key constituents in the cytoplasm from the cell. Read about Sertaconazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ERTACZO Cream	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D01AC14	Sertaconazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 105M98
Country: US	FDA, National Drug Code	Identifier(s): 0187-5115